ChIP and dual‐luciferase reporter assays confirmed that in BLCA cells, c‐Myc directly binds to the promoter of ACLY, increasing its transcriptional activity, whereas RNF112 suppresses the transcriptional activity of ACLY. The gene discussed is ACLY; the disease is bladder transitional cell carcinoma.